Jci_page_head_homepage_01 Jci_page_head_homepage_02
Nichole R. Klatt, Francois Villinger, Pavel Bostik, Shari N. Gordon, Lara Pereira, Jessica C. Engram, Ann Mayne, Richard M. Dunham, Benton Lawson, Sarah J. Ratcliffe, Donald L. Sodora, James Else, Keith Reimann, Silvija I. Staprans, Ashley T. Haase, Jacob D. Estes, Guido Silvestri, Aftab A. Ansari
Published in Volume 118, Issue 6
J Clin Invest. 2008; 118(6):2039–2049 doi:10.1172/JCI33814
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
The observed decline of CD4+ T cells is the result of a true depletion of CD4+ T cells, not of masking by the depleting antibody.

(A) CD3+ T cells in the paracortical region of the LNs were stained by IHC at baseline (–30 d) and 14 d after depletion. (B) Representative contour plot of gating strategy for the analyzed CD3+ T cell subsets: CD4+CD8, CD4CD8+, and CD4CD8 (x axis, CD8; y axis, CD4). Numbers denote percentage of cells within the boxed regions. (C) Longitudinal assessment of the fractions of CD4+CD8, CD4CD8, and CD8+CD4 CD3+ T cells by flow cytometry (average of 6 animals represented). Numbers denote percentage of cells in the indicated subset. (D) Longitudinal assessment of the percent and absolute number of CD8+ T cells (gated on CD3+ lymphocytes) through 240 d after depletion. Dotted lines and tick marks represent CD4-depleting antibody treatment.